Antiretroviral (ARV) Drug Resistance in the Developing World: Evidence Report/Technology Assessment Number 156 by Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

Antiretroviral (ARV) Drug Resistance in the Developing World: Evidence Report/Technology Assessment Number 156

Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

212 pages • missing pub info (view editions)

nonfiction health challenging informative medium-paced
Powered by AI (Beta)
Loading...

Description

The clinical management of HIV infection has greatly improved through the use of highly active antiretroviral therapy (HAART), which comprises the following classes of agents: nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs), non-...

Read more

Community Reviews

Loading...

Content Warnings

Loading...